Navigation Links
Luminex and One Lambda Renew Long-Term Strategic Partnership
Date:12/7/2010

AUSTIN, Texas, Dec. 7, 2010 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX) and One Lambda, Inc., the leading producer of transplant diagnostic products, have agreed to a long-term renewal of their 10-year strategic partnership aimed at developing platforms and technologies for human leukocyte antigen (HLA) typing and antibody screening for the organ transplantation market. Begun in 2000, their dedicated collaboration has resulted in the creation of innovative products that have made pre- and post-transplant diagnostics faster, and more cost-efficient.

(Logo:  http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

"One Lambda and Luminex combined the power of Luminex's xMAP® Technology with One Lambda's expertise in HLA testing and organ transplantation to dramatically advance the care available to those undergoing transplants," said George Ayoub, president and CEO of One Lambda. "Our platforms have significantly enhanced healthcare providers' ability to care for organ transplant patients by delivering vital information that helps them to better match donors with recipients."

Effective diagnostics are essential in transplant medicine. HLA typing and antibody screening are critical in matching organ donors and organ recipients, minimizing rejection and maintaining transplant patients' long-term health following a transplant. This kind of testing can require screening a patient for hundreds of HLA markers and antibodies. One Lambda's dedication to innovation ensures their products are continually updated with the latest donor registry data and new DNA genotypes. The simplicity and flexibility of the xMAP Technology platform to analyze both nucleic acids and proteins has allowed One Lambda to enhance and expand their product menu.

"Luminex and One Lambda have set the
'/>"/>

SOURCE Luminex Corporation; One Lambda, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Luminex Corporation Board of Directors Authorizes Share Repurchase Plan Through November 2011
2. Luminex Corporation Launches New FDA Cleared Pharmacogenetic Diagnostic Test
3. Luminex Corporation to Present at Stephens Fall Investment Conference
4. Luminex Corporation Reports Third Quarter 2010 Results
5. Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2010
6. Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna
7. Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution
8. Luminex Corporation Wins Prestigious 2010 Prix Galien USA Award
9. Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe
10. Luminex Corporation to Present at UBS Global Life Sciences Conference
11. Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Deutschland, und MARSEILLE , ... , Weltweite Exklusivlizenz der ... QIAGEN die Entwicklung von Tests auf SF3B1-Mutationen, ... Neuer Test weist Mutationen des ... (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf vermuten lassen  ...
(Date:7/24/2014)... , July 24, 2014  IRIDEX Corporation (NASDAQ: ... its second quarter 2014 financial results after the market ... conjunction with the release, the Company will host a ... p.m. Eastern Time on Thursday, July 31, ... and other business developments. Interested parties may ...
(Date:7/24/2014)... Columbia and MENLO PARK, Calif. ... (OTCQB: DMPI) ("DelMar" "the company") announced today that the ... fiscal year from December 31 to June 30. Accordingly, DelMar ... 30, 2014. Jeffrey Bacha , president and ... is an important step in achieving our goal of obtaining ...
Breaking Medicine Technology:QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3
... , one of the nation,s largest institutional pharmacy ... as its new senior vice president of sales ... position, Gauff will be responsible for leading a ... Remedi,s innovative offerings, including the continued roll-out of ...
... CareFusion today launched the Nicolet™ EEG (Electroencephalography) ... wave data used for the diagnosis and treatment ... http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO ) The Nicolet EEG ... into a single, portable unit for pediatrics and adults ...
Cached Medicine Technology:Remedi SeniorCare® Appoints Corey Gauff SVP of Sales and Account Management 2CareFusion Launches Wireless Diagnostic and Monitoring Neurological Device 2
(Date:7/24/2014)... Primary care treatment of overweight and obese preschoolers works ... to when only the child is targeted, according to ... conducted at the University at Buffalo and Women and ... were overweight or obese and had one parent who ... obese, according to body mass index (BMI) measurements, calculated ...
(Date:7/24/2014)... or more equally positive outcomes experience paradoxical feelings ... in different regions of the brain, according to ... scholar at the Princeton Neuroscience Institute at Princeton ... rated the desirability of more than 300 products ... images of paired products with different or similar ...
(Date:7/24/2014)... In signing the Workforce Innovation and ... Atlanta BeltLine Workforce Partnership in Healthcare as one ... ( http://www.whitehouse.gov/ready-to-work ). The Administration called for ... economic strategy and profiled successful local efforts to ... Obama highlights the power of partnerships in Atlanta,” ...
(Date:7/24/2014)... 24, 2014 In a recent report by ... officially put an end to criminal penalties associated with possession ... era for marijuana reform in Washington DC, giving it one ... law replaces criminal penalties for possession of one ounce of ... the possession of more than an ounce of marijuana remain ...
(Date:7/24/2014)... 2014 According to market research ... Technology Roadmap, Forecasts and Analysis - 2018", the ... to reach $7.7 billion by 2018 at a ... 102 market data tables and 30 figures spread ... Mapping Market: Global Advancements, Business Models, Technology Roadmap, ...
Breaking Medicine News(10 mins):Health News:Overweight and obese preschoolers lose more weight when parent is also treated 2Health News:Overweight and obese preschoolers lose more weight when parent is also treated 3Health News:Brain's dynamic duel underlies win-win choices 2Health News:Brain's dynamic duel underlies win-win choices 3Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 2Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 3Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 4Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 5Health News:Washington D.C. Decriminalizes Marijuana 2Health News:3D Mapping & 3D Modeling Market Projected to $7.7 Billion by 2018 - Report by MarketsandMarkets 2Health News:3D Mapping & 3D Modeling Market Projected to $7.7 Billion by 2018 - Report by MarketsandMarkets 3Health News:3D Mapping & 3D Modeling Market Projected to $7.7 Billion by 2018 - Report by MarketsandMarkets 4
... HUM ) has,recently released three of its Stay Smart, Stay Healthy ... Stay Healthy videos have racked up more than 1.1 million,hits on ... remained,in the Top 5 videos in education worldwide through December. The ... , "We developed the Stay Smart, Stay ...
... the DNC bolsters firm,s national government affairs practiceWASHINGTON, ... nationally recognized political figure, presidential candidate and six ... an independent consultant exclusive to the government affairs ... Governor Dean will provide guidance to clients, particularly ...
... Than Half of America,s Youth Exceed Recommended Fat Intake; ... Makeover QUINCY, Mass., March 3 Continuing its tradition ... has expanded its NutriFilter sorting feature to include ... program recently launched at sister companies, Stop & ...
... genders regardless of weight issues, study finds , , TUESDAY, March ... than two hours a day or are otherwise inactive have ... , Researchers looked at more than 3,000 children whose ... age. , Each year, parents were asked about any ...
... Each day we have countless conversations with ourselves, and if ... what we say to ourselves is critical, judgmental, and often ... get it, we tend to make excuses and blame others, ... to our assumed shortcomings. Carol Messmer,s new ...
... 3 Catalyst Pharmaceutical Partners, Inc. (Nasdaq: ... develops and commercializes prescription drugs for the treatment of ... product development program. In order to extend its ... halt enrollment of new subjects into its ongoing U.S. ...
Cached Medicine News:Health News:Humana Releases Stay Smart, Stay Healthy Videos in Spanish 2Health News:Howard Dean to Join McKenna Long and Aldridge LLP 2Health News:Howard Dean to Join McKenna Long and Aldridge LLP 3Health News:Peapod Expands NutriFilter Shopping Tool With Healthy Ideas Program 2Health News:Peapod Expands NutriFilter Shopping Tool With Healthy Ideas Program 3Health News:2 Hours Glued to TV Doubles Kids' Asthma Risk 2Health News:'Conversations with Self: Discovering the Power of Your Inner Voice': Discover How to Find and Listen to an Inner Voice That Is Encouraging and Helpful 2Health News:Catalyst to Focus Resources on its Lead Indication for CPP-109; Cocaine Addiction 2Health News:Catalyst to Focus Resources on its Lead Indication for CPP-109; Cocaine Addiction 3
Head-worn Loupe G3, Galilean teleloupe system....
... The XL Advantage delivers higher magnification for ... crisp, true image, even at the highest ... edge clarity and precise color rendition is ... with an anti-reflective coating produce a superior ...
... up of doublet objective and high power ... and 3.0x. The true benefit of this ... maintaining focal clarity is made possible due ... ultra lightweight aluminum bar and individual interpupillary ...
Used for maintaining and forming the anterior chamber by the injection and removal of fluids, air miotics, and viscoeastic substances, as well as keeping the cornea moist during surgery. 4 mm from be...
Medicine Products: